https://www.taxtmi.com/news?id=70125 IKS Health disclosed Q3 FY26 financial results showing INR 8,150 million revenue (24% YoY), INR 2,816 million EBITDA (40% YoY) and INR 1,833 million PAT (41% YoY), attributing margin expansion to operating leverage, technology deployment and cost management, and linking growth to increased adoption of its Care Enablement platform and AI capabilities amid physician reimbursement pressures. en-us Thu, 05 Feb 2026 15:01:05 +0530 Thu, 05 Feb 2026 15:01:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=70125 IKS Health disclosed Q3 FY26 financial results showing INR 8,150 million revenue (24% YoY), INR 2,816 million EBITDA (40% YoY) and INR 1,833 million PAT (41% YoY), attributing margin expansion to operating leverage, technology deployment and cost management, and linking growth to increased adoption of its Care Enablement platform and AI capabilities amid physician reimbursement pressures. News - Thu, 05 Feb 2026 15:01:05 +0530 https://www.taxtmi.com/news?id=70125